Digital Pathology Market Analysis

Digital Pathology Market Analysis

To get key market trends

  Download Free Sample

The market by product is categorized into image analysis software, scanner, and services. The scanner segment garnered USD 496 million revenue size in the year 2022. The scanner segmented is further bifurcated into bright field scanner, fluorescence scanner, combination scanner and others. The increasing demand for combination scanners in digital pathology is propelling market growth due to their versatility, workflow efficiency, and improved diagnostic accuracy.
 

• These devices are at the forefront of technological advancements, enabling a seamless integration of digital pathology into healthcare systems and enhancing patient care.
   
• As digital pathology continues to evolve, combination scanners will play a pivotal role in shaping the future of pathology and contributing to better healthcare outcomes.
   

Based on application, the digital pathology market is segmented into drug discovery & development, disease diagnosis, teleconsultation, and others. The disease diagnosis segment accounted for over 40% business share in the year 2022. High segment share is attributed to higher incidence of relevant diseases and the pressing need for rapid diagnostics.

• According to WHO, by 2030, the proportion of total global deaths due to chronic diseases is expected to increase to 70% indicating the need for faster diagnostic tools. This will lead to escalated adoption of digital pathology to provide faster and more accurate diagnosis.
   
• The integration of digital pathology with EHRs can also improve workflow management by eliminating the need for physical transport of slides and reducing the time required for slide preparation.
   

Overall, the adoption of digital pathology is expected to bring significant benefits to pathology labs, including increased efficiency, accuracy, and cost savings, which can help manage healthcare resources more efficiently.
 

The digital pathology market by end-use is categorized into hospitals, biotech & pharma companies, diagnostic laboratories, academic & research institutes, and others. The diagnostic laboratories segment garnered USD 261 million revenue size in the year 2022.
 

• The adoption of digital pathology in these laboratories has proven instrumental in streamlining processes and enhancing the overall efficiency of diagnostic workflows.
   
• Through the digitization of glass slides into high-resolution whole-slide images, pathologists and laboratory technicians can access and analyze patient samples remotely, reducing turnaround time and minimizing the errors associated with traditional microscopy.
   
• The growing demand for digital pathology by diagnostic laboratories reflects a commitment to advancing diagnostic accuracy, efficiency, and patient outcomes in the ever-evolving landscape of modern healthcare.
   

U.S. digital pathology market accounted for USD 152 million revenue size in 2022 and is predicted to witness substantial market growth during the analysis timeline.

• With the growing importance of technology and data-driven healthcare solutions, digital pathology has gained prominence as a transformative force in pathology and diagnostics in the country.
   
• Furthermore, the U.S. market has been driven by the rising prevalence of chronic diseases, the need for more efficient diagnostic processes, and the integration of these systems with EHR and Laboratory Information Management System (LIMS).